Dr. Barbara Kowalcyk, Executive Director of CFI, Appointed as Chair of FDA Science Board

April 27, 2022
Barbara Kowalcyk

CFI is excited to announce that our Executive Director, Dr. Barbara Kowalcyk, has been appointed as chair of the FDA Science Board. Dr. Kowalcyk was first appointed as a member of the FDA Science Board in 2013 and is honored to be appointed as chair.

Click here to read the OSU press release.